OPEN MARKET SALE AGREEMENTSMEledon Pharmaceuticals, Inc. • March 31st, 2021 • Pharmaceutical preparations • New York
Eledon Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $0.001 per share (the “Common Shares”), having an aggregate offering price of up to $75,000,00 on the terms set forth in this agreement (this “Agreement”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 31st, 2021 • Eledon Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”) is entered into as of September 9, 2020 (the “Effective Date”), by and between Novus Therapeutics, Inc. (the “Company”) and David-Alexandre Gros (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 31st, 2021 • Eledon Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”) is entered into as of March 1, 2021 (the “Effective Date”), by and between Eledon Pharmaceuticals, Inc. (the “Company”) and Jon Kuwahara (“Executive”).
